Medtech Buyers Mull Mega-Mergers, Earn-Outs, And Google
This article was originally published in Start Up
Executive Summary
Even with a surge in IPO opportunities, M&A remains the primary – almost exclusive – exit route for medtech investors and entrepreneurs. A panel of business development professionals speaking at the recent IN3 360° Boston conference presented insights on how start-ups might improve their chances of being acquired.